NASDAQ NMS - GLOBAL MARKET · MIST
-0.43% · -$0.0050 · Vol 600.8K
After hours · updated 16:42:44 ET
Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc

Pharmaceuticals
$1.17
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
MIST
Milestone Pharmaceuticals Inc
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

31/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MIST moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MIST catalysts
About Milestone Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
38
Country
CA

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.20
Day high
$1.20
Day low
$1.13
Previous close
$1.17
52W high
$2.95
-60.51% from high
52W low
$1.01
8% of range
Market cap
$145.7M
EPS
$-0.8300
Beta
2.85
Shares out
124.5M
Volume
600.8K
0.48× rel vol
Avg volume
1.3M
VWAP
$1.16
Price history computed in-house
1W
+12.02%
1M
-11.74%
3M
-38.36%
1Y
-24.35%
YTD
-42.33%
SMA 50 $1.26 · below
SMA 200 $1.75 · below
52W position 8%

MIST overview

Veridion Score
31
4 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MIST.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MIST Form 4 filings
Public disclosures

Congress activity in MIST

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MIST in the cached public ledger.

Federal contracts

MIST contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MIST in this window.
Lobbying spend

MIST lobbying filings, year to date.

Registered lobbying filings matched to Milestone Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MIST in this window.
Loading news for MIST
Analyst ratings
Sovereign unlock shows live analyst consensus for MIST.
Options
Sovereign unlock shows live options positioning for MIST.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.